Physician profile
Eric B Fillinger
NPI 1235102708
$19,356.64
in general payments reported to CMS, 2019-2025
17 companies · $8,756 in 2025
The $8,756 reported for 2025 was more than what 98% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $178 · 2021: $1,438 · 2022: $1,543 · 2023: $2,494 · 2024: $3,938 · 2025: $8,756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,750 · Travel and Lodging: $3,907 · Food and Beverage: $2,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,750.00 |
| Travel and Lodging | $3,907.03 |
| Food and Beverage | $2,531.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,615.43 | 2022-2025 | |
| Prime Surgical, LLC | $2,644.73 | 2023-2025 | |
| Paragon 28, INC. | $1,958.68 | 2019-2021 | |
| Stryker Corporation | $1,123.87 | 2023-2025 | Ortholoc 2 Lapifuse, Prostep, N/A |
| Paratek Pharmaceuticals, INC. | $780.28 | 2023-2025 | Nuzyra |
| Organogenesis INC. | $697.34 | 2019-2024 | Puraply Antimicrobial, Puraply |
| Amgen INC. | $161.11 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $151.11 | 2019-2023 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $73.48 | 2021 | |
| Ani Pharmaceuticals, INC. | $31.38 | 2025 | Purified Cortrophin Gel |
| Vertex Pharmaceuticals Incorporated | $26.99 | 2025 | |
| Kci USA, INC. | $20.03 | 2022 | |
| Trice Medical, INC. | $19.54 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $15.61 | 2025 | Exparel |
| Kowa Pharmaceuticals America, INC. | $15.20 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $11.79 | 2019 | |
| Heron Therapeutics, INC. | $10.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Fillinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.